Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Valeant’s Big Offer for Allergan Big Enough?
Motley Fool
Thursday, June 5, 2014 - 12:22pm
tags:
Valeant Pharmaceuticals, M&A, Allergan
Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Fierce Biotech
Thursday, June 5, 2014 - 12:17pm
tags:
Syndax Pharma, IPOs, breast cancer, breakthrough therapies, entinostat
GSK starts phase III of coronary drug test
Reuters
Thursday, June 5, 2014 - 12:10pm
tags:
GSK, losmapimod, acute coronary syndrome
Bayer says Dieter Weinand to head pharmaceuticals business
Reuters
Thursday, June 5, 2014 - 12:08pm
tags:
Bayer, Dieter Weinand
As FDA Takes Notice of Patients, Groups Trying to Influence Regulatory Policy do as Well
Regulatory Focus
Thursday, June 5, 2014 - 12:06pm
tags:
FDA, patients, PhRMA
Did Retrophin's CEO Share More Than Good Cheer in Twitter Posts?
Bloomberg/Businessweek
Thursday, June 5, 2014 - 12:05pm
tags:
Retrophin, twitter, social media
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Yahoo/Benzinga
Thursday, June 5, 2014 - 12:04pm
tags:
ASCO, cancer immunotherapy, Bristol-Myers Squibb, Yervoy, Merck, MK-3475
Shire’s Best Takeover Defense Is Deal Offense: Real M&A
Bloomberg
Thursday, June 5, 2014 - 12:02pm
tags:
M&A, Shire, NPS Pharmaceuticals
Five Star Biotech Stock Watch: Illumina
Yahoo/Benzinga
Thursday, June 5, 2014 - 12:01pm
tags:
Illumina
Beleaguered biotechs about to rally: Charts
CNBC
Thursday, June 5, 2014 - 11:58am
tags:
biotech
Resverlogix Places A BET On RVX-208
Seeking Alpha
Thursday, June 5, 2014 - 11:54am
tags:
RVX-208, Resverlogix, BET-protein inhibitors, atherosclerosis
Senseonics raised $20 million for its continuous glucose monitor and hired ex-Abbott and LifeScan diabetes executive Mirasol Panlilio to lead its sales & marketing team
Mass Device
Thursday, June 5, 2014 - 11:51am
tags:
diabetes, blood glucose monitoring, Senseonics, devices
What You Need to Know About PTC Therapeutics' Promising DMD Drug
Motley Fool
Thursday, June 5, 2014 - 11:19am
tags:
Duchenne Muscular Dystrophy, PTC Therapeutics, eteplirsen
Northwest Bio Fuzzier on Cancer Vaccine Study Patient Enrollment
TheStreet.com
Thursday, June 5, 2014 - 11:18am
tags:
Northwest Biotherapeutics, glioblastoma, DCVax
ASCO: Bristol-Myers Squibb and Merck Don't Disappoint
Motley Fool
Thursday, June 5, 2014 - 11:17am
tags:
ASCO, Merck, Bristol-Myers Squibb, anti-PD-1 immunotherapy, MK-3475
The 3 Biggest Biotech Crashes in May
Motley Fool
Thursday, June 5, 2014 - 9:31am
tags:
Clovis Oncology, INSYS Therapeutics, Aegerion Pharmaceuticals
Three Biotechs That Could Double
Yahoo/Street Authority
Thursday, June 5, 2014 - 9:29am
tags:
Verastem, Versartis, Threshold Pharmaceuticals
The Expected Rise and Inevitable Fall of MannKind
TheStreet.com
Thursday, June 5, 2014 - 9:27am
tags:
MannKind, Afrezza, diabetes, Arena Pharmaceuticals, Belviq
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Yahoo/Benzinga
Thursday, June 5, 2014 - 9:14am
tags:
ASCO, Pfizer, Aromasin, tamoxifen, DARA Biosciences, breast cancer, Herceptin, Tykerb, GSK, Eli Lilly, Bristol-Myers Squibb, Erbitux
Medtronic Said to Evaluate Takeover of Smith & Nephew
Bloomberg
Wednesday, June 4, 2014 - 3:24pm
tags:
Smith & Nephew, Medtronic, M&A, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.